NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study

BACKGROUND: Cell surface NKG2D ligands (NKG2DL) bind to the activating NKG2D receptor present on NK cells and subsets of T cells, thus playing a role in initiating an immune response. We examined tumor expression and prognostic effect of NKG2DL in breast cancer patients. METHODS: Our study populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: de Kruijf, Esther M, Sajet, Anita, van Nes, Johanna GH, Putter, Hein, Smit, Vincent THBM, Eagle, Robert A, Jafferji, Insiya, Trowsdale, John, Liefers, Gerrit Jan, van de Velde, Cornelis JH, Kuppen, Peter JK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292504/
https://www.ncbi.nlm.nih.gov/pubmed/22257486
http://dx.doi.org/10.1186/1471-2407-12-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292504/
https://www.ncbi.nlm.nih.gov/pubmed/22257486
http://dx.doi.org/10.1186/1471-2407-12-24

Ejemplares similares